Annual long term liabilities:
$5.83M+$503.00K(+9.44%)Summary
- As of today (September 19, 2025), CLDX annual total long term liabilities is $5.83 million, with the most recent change of +$503.00 thousand (+9.44%) on December 31, 2024.
- During the last 3 years, CLDX annual long term liabilities has fallen by -$2.82 million (-32.55%).
- CLDX annual long term liabilities is now -92.95% below its all-time high of $82.70 million, reached on December 31, 2016.
Performance
CLDX Long term liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly long term liabilities:
$4.04M-$434.00K(-9.70%)Summary
- As of today (September 19, 2025), CLDX quarterly total long term liabilities is $4.04 million, with the most recent change of -$434.00 thousand (-9.70%) on June 1, 2025.
- Over the past year, CLDX quarterly long term liabilities has dropped by -$231.00 thousand (-5.41%).
- CLDX quarterly long term liabilities is now -95.30% below its all-time high of $85.83 million, reached on June 30, 2017.
Performance
CLDX quarterly long term liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Long term liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
CLDX Long term liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +9.4% | -5.4% |
| 3 y3 years | -32.5% | -49.0% |
| 5 y5 years | -66.2% | -66.7% |
CLDX Long term liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -32.5% | +9.4% | -49.0% | +2.4% |
| 5 y | 5-year | -66.2% | +9.4% | -70.3% | +2.4% |
| alltime | all time | -93.0% | >+9999.0% | -95.3% | +4138.0% |
CLDX Long term liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $4.04M(-9.7%) |
| Mar 2025 | - | $4.47M(-23.3%) |
| Dec 2024 | $5.83M(+9.4%) | $5.83M(+12.6%) |
| Sep 2024 | - | $5.18M(+21.4%) |
| Jun 2024 | - | $4.27M(+8.3%) |
| Mar 2024 | - | $3.94M(-26.0%) |
| Dec 2023 | $5.33M(-32.7%) | $5.33M(-6.5%) |
| Sep 2023 | - | $5.70M(-7.0%) |
| Jun 2023 | - | $6.13M(-6.6%) |
| Mar 2023 | - | $6.56M(-17.2%) |
| Dec 2022 | $7.92M(-8.4%) | $7.92M(+5.3%) |
| Sep 2022 | - | $7.52M(-5.0%) |
| Jun 2022 | - | $7.92M(-30.4%) |
| Mar 2022 | - | $11.38M(+31.6%) |
| Dec 2021 | $8.65M(-29.5%) | $8.65M(-7.1%) |
| Sep 2021 | - | $9.31M(+19.7%) |
| Jun 2021 | - | $7.78M(-1.8%) |
| Mar 2021 | - | $7.92M(-35.5%) |
| Dec 2020 | $12.28M(-28.9%) | $12.28M(-9.7%) |
| Sep 2020 | - | $13.60M(+12.2%) |
| Jun 2020 | - | $12.12M(-32.2%) |
| Mar 2020 | - | $17.87M(+3.5%) |
| Dec 2019 | $17.26M(-9.8%) | $17.26M(-7.0%) |
| Sep 2019 | - | $18.57M(-12.0%) |
| Jun 2019 | - | $21.11M(-7.8%) |
| Mar 2019 | - | $22.89M(+19.6%) |
| Dec 2018 | $19.15M(-62.8%) | $19.15M(-17.8%) |
| Sep 2018 | - | $23.30M(-23.2%) |
| Jun 2018 | - | $30.35M(-8.8%) |
| Mar 2018 | - | $33.28M(-35.4%) |
| Dec 2017 | $51.52M(-37.7%) | $51.52M(-31.6%) |
| Sep 2017 | - | $75.35M(-12.2%) |
| Jun 2017 | - | $85.83M(+0.7%) |
| Mar 2017 | - | $85.19M(+3.0%) |
| Dec 2016 | $82.70M(+379.7%) | $82.70M(+409.7%) |
| Sep 2016 | - | $16.23M(-1.6%) |
| Jun 2016 | - | $16.49M(-0.6%) |
| Mar 2016 | - | $16.59M(-3.8%) |
| Dec 2015 | $17.24M(+45.3%) | $17.24M(+66.2%) |
| Sep 2015 | - | $10.37M(-2.6%) |
| Jun 2015 | - | $10.65M(-3.2%) |
| Mar 2015 | - | $11.00M(-7.3%) |
| Dec 2014 | $11.86M(+70.7%) | $11.86M(+11.1%) |
| Sep 2014 | - | $10.68M(-3.6%) |
| Jun 2014 | - | $11.07M(+50.8%) |
| Mar 2014 | - | $7.35M(+5.7%) |
| Dec 2013 | $6.95M(-42.5%) | $6.95M(-0.5%) |
| Sep 2013 | - | $6.99M(+12.8%) |
| Jun 2013 | - | $6.19M(-0.3%) |
| Mar 2013 | - | $6.21M(-48.6%) |
| Dec 2012 | $12.08M(-19.3%) | $12.08M(+92.4%) |
| Sep 2012 | - | $6.28M(+0.8%) |
| Jun 2012 | - | $6.23M(-0.5%) |
| Mar 2012 | - | $6.26M(-58.2%) |
| Dec 2011 | $14.97M(+158.4%) | $14.97M(+175.3%) |
| Sep 2011 | - | $5.44M(+0.0%) |
| Jun 2011 | - | $5.44M(-16.5%) |
| Mar 2011 | - | $6.51M(+12.4%) |
| Dec 2010 | $5.80M(-88.9%) | $5.80M(-85.8%) |
| Sep 2010 | - | $40.90M(+10.1%) |
| Jun 2010 | - | $37.14M(-5.2%) |
| Mar 2010 | - | $39.16M(-25.0%) |
| Dec 2009 | $52.19M(+39.0%) | $52.19M(+44.0%) |
| Sep 2009 | - | $36.23M(-2.7%) |
| Jun 2009 | - | $37.25M(-1.0%) |
| Mar 2009 | - | $37.64M(+0.2%) |
| Dec 2008 | $37.56M(>+9900.0%) | $37.56M(+1.7%) |
| Sep 2008 | - | $36.92M(+0.5%) |
| Jun 2008 | - | $36.75M(+3063.2%) |
| Mar 2008 | - | $1.16M(+214.0%) |
| Dec 2007 | $370.00K(-99.2%) | $370.00K(-99.2%) |
| Sep 2007 | - | $48.59M(-2.0%) |
| Jun 2007 | - | $49.58M(+4.4%) |
| Mar 2007 | - | $47.50M(-3.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2006 | $49.23M(+314.8%) | $49.23M(+2.3%) |
| Sep 2006 | - | $48.12M(-2.1%) |
| Jun 2006 | - | $49.15M(+1.1%) |
| Mar 2006 | - | $48.61M(+309.5%) |
| Dec 2005 | $11.87M(+464.2%) | $11.87M(+0.7%) |
| Sep 2005 | - | $11.79M(-0.5%) |
| Jun 2005 | - | $11.85M(+519.2%) |
| Mar 2005 | - | $1.91M(-9.0%) |
| Dec 2004 | $2.10M(>+9900.0%) | $2.10M(+513.9%) |
| Sep 2004 | - | $342.70K(>+9900.0%) |
| Jun 2004 | - | $0.00(0.0%) |
| Mar 2004 | - | $0.00(0.0%) |
| Dec 2003 | $0.00(-100.0%) | $0.00(-100.0%) |
| Sep 2003 | - | $82.90K(-60.0%) |
| Jun 2003 | - | $207.40K(-37.5%) |
| Mar 2003 | - | $331.80K(-27.3%) |
| Dec 2002 | $456.20K(-83.1%) | $456.20K(+196.2%) |
| Sep 2002 | - | $154.00K(-92.0%) |
| Jun 2002 | - | $1.92M(-16.7%) |
| Mar 2002 | - | $2.31M(-14.3%) |
| Dec 2001 | $2.69M(-36.4%) | $2.69M(-12.5%) |
| Sep 2001 | - | $3.08M(-11.1%) |
| Jun 2001 | - | $3.46M(-10.0%) |
| Mar 2001 | - | $3.85M(-9.1%) |
| Dec 2000 | $4.23M(+1472.4%) | $4.23M(+59.1%) |
| Sep 2000 | - | $2.66M(-7.9%) |
| Jun 2000 | - | $2.89M(-7.4%) |
| Mar 2000 | - | $3.12M(+1058.6%) |
| Dec 1999 | $269.20K(-51.1%) | $269.20K(-32.7%) |
| Sep 1999 | - | $400.00K(0.0%) |
| Jun 1999 | - | $400.00K(-33.3%) |
| Mar 1999 | - | $600.00K(+9.1%) |
| Dec 1998 | $550.10K(-21.4%) | $550.10K(-54.2%) |
| Sep 1998 | - | $1.20M(+50.0%) |
| Jun 1998 | - | $800.00K(0.0%) |
| Mar 1998 | - | $800.00K(+14.3%) |
| Dec 1997 | $700.00K(>+9900.0%) | $700.00K(-53.3%) |
| Sep 1997 | - | $1.50M(>+9900.0%) |
| Jun 1997 | - | $0.00(-100.0%) |
| Mar 1997 | - | -$100.00K(<-9900.0%) |
| Dec 1996 | $4500.00(-95.5%) | $0.00(-100.0%) |
| Sep 1996 | - | $200.00K(+100.0%) |
| Jun 1996 | - | $100.00K(0.0%) |
| Mar 1996 | - | $100.00K(0.0%) |
| Dec 1995 | $100.00K(-80.0%) | $100.00K(-50.0%) |
| Sep 1995 | - | $200.00K(0.0%) |
| Jun 1995 | - | $200.00K(-50.0%) |
| Mar 1995 | - | $400.00K(-20.0%) |
| Dec 1994 | $500.00K(-16.7%) | $500.00K(0.0%) |
| Sep 1994 | - | $500.00K(+25.0%) |
| Jun 1994 | - | $400.00K(-20.0%) |
| Mar 1994 | - | $500.00K(-16.7%) |
| Dec 1993 | $600.00K(>+9900.0%) | $600.00K(>+9900.0%) |
| Sep 1993 | - | $0.00(0.0%) |
| Jun 1993 | - | $0.00(0.0%) |
| Mar 1993 | - | $0.00(0.0%) |
| Dec 1992 | $0.00(0.0%) | - |
| Oct 1992 | - | $0.00(0.0%) |
| Jul 1992 | - | $0.00(0.0%) |
| Apr 1992 | - | $0.00(0.0%) |
| Apr 1992 | $0.00(0.0%) | - |
| Jan 1992 | - | $0.00(-100.0%) |
| Oct 1991 | - | $100.00K(>+9900.0%) |
| Jul 1991 | - | $0.00(0.0%) |
| Apr 1991 | $0.00(0.0%) | $0.00(0.0%) |
| Jan 1991 | - | $0.00(0.0%) |
| Oct 1990 | - | $0.00(0.0%) |
| Jul 1990 | - | $0.00(0.0%) |
| Apr 1990 | $0.00(-100.0%) | $0.00(0.0%) |
| Jan 1990 | - | $0.00(-100.0%) |
| Apr 1989 | $2.30M(-4.2%) | $2.30M(-4.2%) |
| Apr 1988 | $2.40M(-4.0%) | $2.40M(-4.0%) |
| Apr 1987 | $2.50M(-51.9%) | $2.50M(-51.9%) |
| Apr 1986 | $5.20M | $5.20M |
FAQ
- What is Celldex Therapeutics, Inc. annual total long term liabilities?
- What is the all time high annual long term liabilities for Celldex Therapeutics, Inc.?
- What is Celldex Therapeutics, Inc. annual long term liabilities year-on-year change?
- What is Celldex Therapeutics, Inc. quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Celldex Therapeutics, Inc.?
- What is Celldex Therapeutics, Inc. quarterly long term liabilities year-on-year change?
What is Celldex Therapeutics, Inc. annual total long term liabilities?
The current annual long term liabilities of CLDX is $5.83M
What is the all time high annual long term liabilities for Celldex Therapeutics, Inc.?
Celldex Therapeutics, Inc. all-time high annual total long term liabilities is $82.70M
What is Celldex Therapeutics, Inc. annual long term liabilities year-on-year change?
Over the past year, CLDX annual total long term liabilities has changed by +$503.00K (+9.44%)
What is Celldex Therapeutics, Inc. quarterly total long term liabilities?
The current quarterly long term liabilities of CLDX is $4.04M
What is the all time high quarterly long term liabilities for Celldex Therapeutics, Inc.?
Celldex Therapeutics, Inc. all-time high quarterly total long term liabilities is $85.83M
What is Celldex Therapeutics, Inc. quarterly long term liabilities year-on-year change?
Over the past year, CLDX quarterly total long term liabilities has changed by -$231.00K (-5.41%)